H., & Sharifi, A
With Smart Rx , Noom Med rewires the traditional GLP-1 supply chain, bypassing pharmacy benefit managers (PBMs) and connecting employers directly to brand-name medications at substantially lower cost

type 2 diabetes: differences, risk factors, diagnosis Prediabetes evaluation & glucose tolerance testing Diabetic neuropathy: exam, diagnosis & treatment Vascular disease: diagnosis, ankle-brachial index & treatment Hypoglycemia: recognition, management & patient education Dietary management: glycemic index, load & response Exercise in the diabetic patient Practice topics Documentation & charting for diabetes management visits Insurance billing, coding & cash pay pricing Complementary niche services to pair with diabetes care Course 3: The IV Infusion & Injectable Clinic Course $499 * 8 CE * 4 Rx Sam Kakaes, MSN, APRN, FNP-BC The definitive guide to turning your practice into an IV infusion hub covering everything from clinical protocols and equipment setup through compounding pharmacy relationships, regulatory compliance, and revenue-generating service package design

Analysts project oral drugs could represent approximately 20% of the estimated $80 billion GLP-1 obesity market by 2030 [47]
More Blog Posts Blog Post August 03, 2026 This National Wellness Month, borrow these 6 wellbeing ideas from the world's biggest brands Blog Post July 27, 2026 How do we get employees to the best doctor
Discontinue use and consult a healthcare provider if you experience persistent or concerning symptoms